HMGB1 and metabolic dysfunction-associated steatotic liver disease: HMGB1 was also increased in the plasma in a mouse model of nonalcoholic fatty liver disease (NAFLD) induced by high fat diet and use of HMGB1-neutralizing antibody improved liver inflammation although there was no improvement on liver lipid accumulation [58].